For Anyone Keen To See “Dumb Money”, Here’s The Cast, Who They Play, And Where You Might Know Them From
I still don't understand stocks, tbf.View Entire Post ›...
33 Cool And Cheap Beauty Products Worth Treating Yourself To
Budget alternatives to splurge-worthy makeup, a cleanser that'll change your life, and the *cutest* nail designs — all just an "add to cart" away.View Entire Post ›...
Multiple people are feared trapped after home explosion in New Jersey
Multiple people are feared to be trapped following a home explosion in New Jersey on Friday night...
“The Crown” Star Emma Corrin And “Bohemian Rhapsody” Actor Rami Malek Were Spotted Kissing This Week, Seemingly Confirming That They’re An Item
I know the eye contact in that house is unsettling as hell."View Entire Post ›...
New Orleans declares state of emergency as saltwater creeps up drought-stricken Mississippi river and threatens drinking water for nearly 900,000 residents
A saltwater intrusion in the water supply that's pumped out of the Mississippi river is threatening the drinking water of nearly 900,000 residents, who now must rethink everyday activities...
Hands-on with Surface Laptop Go 3 and Surface Laptop Studio 2
At Microsoft’s fall event today, the company’s signature tablets appear to be a no-show. But that doesn’t mean there’s no new hardware to show off. Both the low-price Surface Laptop Go and the high-end Surface Laptop Studio are getting refreshed with new chips, the latest Windows 11 AI-focused features...
Microsoft makes its Surface Go 4 tablet a tool for professionals
Microsoft has apparently decided to make the Surface Go line of tiny tablets a purely business device, announcing the Surface Go 4 for Business but without a consumer option. What’s new? The lack of Arm options and a new Intel processor. Intel Microsoft didn’t reveal a starting price for the Surface Go 4 for Business...
10 historic hotels with amazing views of fall foliage
From a castle-like resort in Quebec City to a hot springs retreat in the Arizona desert, these stays come with colorful scenery and stories.
Vividion Therapeutics starts Phase I clinical trial in advanced solid tumors with KEAP1 activator
Berlin, Germany, San Diego, CA, USA, September 18, 2023 – Vividion Therapeutics, Inc. (Vividion), announced today that it has initiated dosing of patients in a Phase I oncology clinical trial of its investigational oral Kelch-like ECH Associated Protein 1 (KEAP1) activator, VVD-130037. Vividion is a biopharmaceutical company utilizing novel discovery technologies to unlock high value...
